Considering Aeva Technologies Inc (AEVA) as a potential investment: What Should You Do?

As of close of business last night, Aeva Technologies Inc’s stock clocked out at $1.00, down -14.53% from its previous closing price of $1.17. In other words, the price has decreased by -$0.1700 from its previous closing price. On the day, 4340680 shares were traded. AEVA stock price reached its highest trading level at $1.2500 during the session, while it also had its lowest trading level at $0.9700.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.


To gain a deeper understanding of AEVA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 16.30 and its Current Ratio is at 16.48. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Sandler on July 18, 2022, Downgraded its rating to Neutral and sets its target price to $3 from $5 previously.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 20 when Zadesky Stephen Paul sold 43,604 shares for $0.56 per share. The transaction valued at 24,553 led to the insider holds 56,105 shares of the business.

Sylebra Capital Ltd bought 24,795,027 shares of AEVA for $14,455,501 on Nov 09. The 10% Owner now owns 51,896,560 shares after completing the transaction at $0.58 per share. On Feb 06, another insider, Dardashti Soroush Salehian, who serves as the Chief Executive Officer of the company, sold 35,851 shares for $2.02 each. As a result, the insider received 72,283 and left with 23,824,040 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AEVA now has a Market Capitalization of 260.79M and an Enterprise Value of 34.94M. For the stock, the TTM Price-to-Sale (P/S) ratio is 77.50 while its Price-to-Book (P/B) ratio in mrq is 0.91. Its current Enterprise Value per Revenue stands at 12.10 whereas that against EBITDA is -0.24.

Stock Price History:

Over the past 52 weeks, AEVA has reached a high of $2.10, while it has fallen to a 52-week low of $0.47. The 50-Day Moving Average of the stock is 0.6595, while the 200-Day Moving Average is calculated to be 0.9549.

Shares Statistics:

It appears that AEVA traded 1.14M shares on average per day over the past three months and 2.7M shares per day over the past ten days. A total of 218.75M shares are outstanding, with a floating share count of 114.36M. Insiders hold about 48.94% of the company’s shares, while institutions hold 55.60% stake in the company. Shares short for AEVA as of Dec 14, 2023 were 7.56M with a Short Ratio of 7.56M, compared to 4.91M on Nov 14, 2023. Therefore, it implies a Short% of Shares Outstanding of 2.90% and a Short% of Float of 4.95%.

Earnings Estimates

As of right now, Teva Pharmaceutical Industries analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is $1.00, with high estimates of $36.21 and low estimates of $0.91.

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular